Citation | Vazquez, ML; Kaila, N; Strohbach, JW; Trzupek, JD; Brown, MF; Flanagan, ME; Mitton-Fry, MJ; Johnson, TA; TenBrink, RE; Arnold, EP; Basak, A; Heasley, SE; Kwon, S; Langille, J; Parikh, MD; Griffin, SH; Casavant, JM; Duclos, BA; Fenwick, AE; Harris, TM; Han, S; Caspers, N; Dowty, ME; Yang, X; Banker, ME; Hegen, M; Symanowicz, PT; Li, L; Wang, L; Lin, TH; Jussif, J; Clark, JD; Telliez, JB; Robinson, RP; Unwalla, R Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. J Med Chem61:1130-1152 (2018) [PubMed] Article |
---|
SMILES | CN([C@@H]1C[C@@H](C1)NS(=O)(=O)C1CC1)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(5.58,-12.63,;6.92,-13.39,;8.25,-12.62,;8.64,-11.13,;10.12,-11.52,;9.73,-13.01,;11.45,-10.75,;12.78,-11.51,;13.54,-12.83,;12.01,-12.83,;14.12,-10.74,;15.66,-10.74,;14.89,-9.4,;6.92,-14.93,;5.6,-15.7,;5.59,-17.24,;6.93,-18.01,;8.26,-17.23,;9.73,-17.7,;10.63,-16.45,;9.72,-15.21,;8.25,-15.69,)| |